Home /
Chemotherapy & Immunotherapy – Istituto Clinico Humanitas
|
|
Description: |
Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before.
Treatment: The treatment consisted of the chemotherapy drugs cisplatin (platinol) and doxorubicin (adriamycin) with alpha-2b interferon. Toxicity: Grade 4 toxicities included hematologic and renal. Results: The median survival was 9.3 months. Correspondence: Hector Soto Parra |